MedTrace Logo

Anterior Cruciate Ligament Pain Study

NCT02604550 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 115

Last updated 2017-05-31

Study results available
· View outcomes & findings →

Summary

The objective of this study is to compare the pain control benefit of two different types of nerve blocks in patients undergoing anterior cruciate ligament (ACL) reconstruction.

Conditions

  • Anterior Cruciate Ligament Reconstruction

Interventions

DRUG

Ropivacaine 0.5%

Ropivacaine 0.5% will be administered to the femoral nerve or adductor canal.

DRUG

Percocet 7.5/325

Percocet 7.5/325 will taken as needed up to every four hours.

DRUG

Naprosyn 500 mg

Naprosyn 500 mg will be taken twice daily.

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • John Xerogeanes, MD · Emory University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02604550 on ClinicalTrials.gov